Wafik S. El-Deiry, Director of Legorreta Cancer Center at Brown University and Chair of the WIN Consortium in Cancer Personalized Medicine, shared on X:
“The WIN International Molecular Tumor Board Session at the 2026 WIN Symposium, Rhode Island Convention Center, Providence, RI
Chair:
- Razelle Kurzrock, MD, FACP, CMO, WIN Consortium, Chevilly-Larue, France, Chair, WIN International MTB
Co-Chairs:
- Wafik El-Deiry, MD, PhD, FACP, Chair, WIN Consortium, Chevilly-Larue, France and Brown University Health, Providence, RI, USA
- Sewanti A. Limaye, MBBS, MD, MS Sir H.N. Reliance Foundation Hospital and Research Centre, Mumbai, India
Panelists:
- Vivek Subbiah, MD Stanford Cancer Center, Palo Alto, CA, USA
- Giselle L. Saulnier Sholler, MD, Penn State Health, Founder, Beat Childhood Cancer Research Consortium
- Bicky Thapa, MD, MS, FACP, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA, USA
Multi-disciplinary live case discussion with audience participation included.
The WIN Consortium Molecular Tumor Board discussed a case of diffuse hemispheric glioma with H3G34R mutation at the recent WIN Symposium in Rhode Island on October 2nd, 2026. Great discussion by the assembled leaders in precision oncology and great audience questions as well.
Title: H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Diffuse Hemispheric Gliomas
Authors: Maria B. Garcia-Fabiani, Santiago Haase, Kaushik Banerjee, Ziwen Zhu, Brandon L. McClellan, Anzar A. Mujeeb, Yingxiang Li, Claire E. Tronrud, Maria L. Varela, Molly E.J. West, Jin Yu, Padma Kadiyala, Ayman W. Taher, Felipe J. Núñez, Mahmoud S. Alghamri, Andrea Comba, Flor M. Mendez, Alejandro J. Nicola Candia, Brittany Salazar, Fernando M. Nunez, Marta B. Edwards, Tingting Qin, Rodrigo T. Cartaxo, Michael Niculcea, Carl Koschmann, Sriram Venneti, Montserrat Puigdelloses Vallcorba, Emon Nasajpour, Giulia Pericoli, Maria Vinci, Claudia L. Kleinman, Nada Jabado, James P. Chandler, Adam M. Sonabend, Michael DeCuypere, Dolores Hambardzumyan, Laura M. Prolo, Kelly B. Mahaney, Gerald A. Grant, Claudia K. Petritsch, Joshua D. Welch, Maureen A. Sartor, Pedro R. Lowenstein, Maria G. Castro
Read the Full Article
Industry Perspectives: Genomic Profiling, Next-Generation Drugs and Precision Oncology
Moderator:
- Bob Cormier, President and CEO of the Rhode Island Life Science Hub, Providence, RI, USA
Panelists:
- Zachary Boyd, MS, PhD, VP, Precision Medicine and Companion Diagnostics, J/J, Thousand Oaks, CA, USA
- John Tarantino, JD, CEO, Iylon, Providence, RI, USA
- David Spetzler, MS, PhD, MBA, President, Caris Life Sciences, Paradise Valley, AZ, USA
- Navid Alipour, JD, MBA, Co-Founder and CEO, Curematch, San Diego, CA, USA
- Nesrin Erkol, PhD, CEO, Vaccizone Biotechnology, Turkey
- Bradley Sander, CEO, p53-Therapeutics, Providence, RI, USA
- Emile Youssef, MD, PhD, CMO, p53-Therapeutics, Providence, RI, USA
Although requested and supported by the Chair of the WIN Consortium and a Letter of Support from United States Senator Jack Reed from Rhode Island, Professor Nesrin Erkol, who was invited, could not get an interview or obtain a Visa to travel from Turkey to the United States to participate in the 2026 WIN Symposium in Rhode Island as a Symposium Sponsor, Poster Presenter, and panelist for the Industry Perspectives Panel.
Professor Erkol was planning to provide a global industry perspective and has expressed interest in being part of the RI biotech ecosystem to promote the operations and impact of her company Vaccizone Biotechnology.
Panel Discussion on Pharma Managed Access Programs at the 2026 WIN Symposium in Providence, Rhode Island on October 2nd, 2026
Pharma Managed Access Programs
Moderator:
- Jeffrey R. Waldron, MBA, Sherborn Consulting
Panelists:
- Harpreet Ram, MBA, EVR Consulting LLC, NJ, USA
- Lea Ann Browning-McNee, MS, Reagan-Udall Foundation for the FDA, Frederick, MD, USA
- Annie Drelles, MPH, Daiichi Sankyo, Stoughton, MA, USA
You may also be interested in: Vivek Subbiah: Bringing the Global Precision Oncology Community Together at WIN Symposium 2026
